- 全部删除
您的购物车当前为空
PDE4B-IN-2 (A 33) 是一种具有口服活性,选择性 PDE4B 抑制剂,IC50 为 15 nM。PDE4B-IN-2 抑制 PDE4D (IC50=1.7 µM)。PDE4B-IN-2 表现出有效的抗炎作用。

PDE4B-IN-2 (A 33) 是一种具有口服活性,选择性 PDE4B 抑制剂,IC50 为 15 nM。PDE4B-IN-2 抑制 PDE4D (IC50=1.7 µM)。PDE4B-IN-2 表现出有效的抗炎作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 295 | In stock | |
| 5 mg | ¥ 747 | In stock | |
| 10 mg | ¥ 1,160 | In stock | |
| 25 mg | ¥ 2,320 | In stock | |
| 50 mg | ¥ 3,730 | In stock | |
| 100 mg | ¥ 5,450 | In stock | |
| 500 mg | ¥ 11,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 822 | In stock |
PDE4B-IN-2 相关产品
| 产品描述 | PDE4B-IN-2 (A 33) is an orally active and selective PDE4B inhibitor with an IC50 of 15 nM. PDE4B-IN-2 inhibits PDE4D (IC50=1.7 µM). PDE4B-IN-2 exhibits potent anti-inflammatory effects. |
| 靶点活性 | PDE4D:1.7 μM (IC50), PDE4B:15 nM (IC50) |
| 体外活性 | PDE4B-IN-2 (compound 33) does not inhibit CYP1A2, CYP3A4, CYP2C9, and CYP2D (IC50>10 µM). PDE4B-IN-2 inhibits LPS-induced TNF-aproduction in vitro from mouseperipheral blood mononuclear cell (PBMC; IC50=0.5 M)[1]. |
| 体内活性 | PDE4B-IN-2 (compound 33; 2 mg/kg; po) has a Cmax of 8.7 μg/mL and an AUC of 52.3 μg•h/mL in mice[1]. |
| 别名 | A 33 |
| 分子量 | 387.88 |
| 分子式 | C19H18ClN3O2S |
| CAS No. | 915082-52-9 |
| Smiles | CCc1c(C)nc(nc1Nc1ccc(CC(O)=O)cc1)-c1ccc(Cl)s1 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 22.5 mg/mL (58 mM), Sonication and heating to 60℃ are recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容